Liposomes: A New Approch for Transdermal Drug Delivery System

Abstract

Scientist Alec Bangham had done exceptional research for discovery of liposomes in mid era of 1960s, these phospholipid vesicles are used as pharmaceutical carriersLiposomes comprise lipid vesicles, which have evolved from a self-forming bilayer of enclosed lipid while the central domain is hydrated. • Liposome preparations recently aimed at reverse toxicity scale and improve goal site aggregation.Phospholipid vesicles, among the most applied techniques in TDDS for the recapitulate and transfer of bioactive materials and various compounds in pharmaceutical ,biological, medical and nutritional research. • The strength of application may be greatly compromised by its administration. The advancement in pharmacodynamics, pharmacokinetics, safety, immunological and effectiveness of medications is now being dodone by the production of a range of drug delivery systems (DDSs). • It is possible to "optimize" the efficiency of the medication within the bodies by determining the most effective distribution route for a given medication molecule. • We look at the different forms of administration here, discover what a "product distribution device" actually for and illustrate essential mechanisms for medication distribution. • The most efficient and effective management with many types with narcotics such as antimicrobials, antibacterial, antiviral, anti-tuberculosis and gene therapy is done through the administration of transdermal medications. Transdermal drug care